Literature DB >> 18443020

Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes.

Sharad I Wadhwani1, Yumirle P Turmelle, Rosemary Nagy, Jeffrey Lowell, Patrick Dillon, Ross W Shepherd.   

Abstract

Age at diagnosis is a modifiable risk factor in outcomes after hepatoportoenterostomy in biliary atresia; however, distinguishing biliary atresia from other more common causes of prolonged neonatal jaundice can be difficult. To focus attention on diagnosis of biliary atresia, we analyzed secular trends in the age at diagnosis, and other factors that might influence outcome. We performed a retrospective analysis of 55 consecutive infants with biliary atresia presenting to a single academic pediatric center over 15-year period from 1990 to 2004. The median age at diagnosis was 60 days (range: 21-152). In recent era (2000-2004), the median age was 69.0 days, compared with 48.5 days (1990-1994) and 59.5 days (1995-1999), respectively. Consistent with previous studies, the median age at diagnosis of those with poor outcomes (death or liver transplant) exceeded those with good outcomes after the hepatoportoenterostomy (72 vs 52 days, P < .001). The lack of improvement, or a concerning trends toward an increase in the age at diagnosis of biliary atresia, is perhaps attributable to neonatal follow-up practices. Efforts to make an earlier diagnose of this important condition deserve wider application and study.

Entities:  

Mesh:

Year:  2008        PMID: 18443020     DOI: 10.1542/peds.2007-2709

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  RRAS: A key regulator and an important prognostic biomarker in biliary atresia.

Authors:  Rui Zhao; Hao Li; Chun Shen; Shan Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

2.  Measurement of serum TNF alpha as a sensitive and specific marker in diagnosing extrahepatic biliary atresia.

Authors:  Mohammadreza Fariborzi; Fatemeh Farahmand; Gholamhosein Fallahi; Mohammadtaghi Ashtyani; Masumeh Hashemi; Azadeh Kiumarsi; Mohammadmahdi Allameh
Journal:  Indian J Gastroenterol       Date:  2014-09

3.  Clinical and pathological features of patients with biliary atresia who survived for more than 5 years with native liver.

Authors:  Song Sun; Shan Zheng; Xuexin Lu; Gong Chen; Yangyang Ma; Lian Chen; Kuiran Dong
Journal:  Pediatr Surg Int       Date:  2018-02-09       Impact factor: 1.827

4.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

5.  Comparison of laparoscopic portoenterostomy and open portoenterostomy for the treatment of biliary atresia.

Authors:  Yanan Li; Jinran Gan; Chuan Wang; Zhicheng Xu; Yiyang Zhao; Yi Ji
Journal:  Surg Endosc       Date:  2019-06-12       Impact factor: 4.584

Review 6.  Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis.

Authors:  Min-Zhong Zhang; Peng-Cheng Xun; Ka He; Wei Cai
Journal:  World J Pediatr       Date:  2016-10-15       Impact factor: 2.764

7.  Neonatal cholestasis: opportunities to increase early detection.

Authors:  Joseph J Palermo; Shannon Joerger; Yumirle Turmelle; Peter Putnam; Jane Garbutt
Journal:  Acad Pediatr       Date:  2012-05-26       Impact factor: 3.107

Review 8.  Early and Peri-operative Prognostic Indicators in Infants Undergoing Hepatic Portoenterostomy for Biliary Atresia: a Review.

Authors:  Robert N Lopez; Chee Y Ooi; Usha Krishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-04

9.  Biliary atresia screening: why, when, and how?

Authors:  Ronald J Sokol
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

10.  Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements.

Authors:  Sanjiv Harpavat; Joseph A Garcia-Prats; Carlos Anaya; Mary L Brandt; Philip J Lupo; Milton J Finegold; Alice Obuobi; Adel A ElHennawy; William S Jarriel; Benjamin L Shneider
Journal:  JAMA       Date:  2020-03-24       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.